Ticker Details
CareDx, Inc. CareDx Inc is a commercial stage company. It develops, markets and delivers a diagnostic surveillance solution for heart transplant recipients to help clinicians make personalized treatment decisions throughout a transplant patient's lifetime.
IPO Date:	July 17, 2014
Sector:	Healthcare
Industry:	Diagnostics and Research
Market Cap:	$1.12B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.62 | 3.05%
Avg Daily Range (30 D):	$0.50 | 2.44%
Avg Daily Range (90 D):	$0.46 | 2.36%

Institutional Daily Volume
Avg Daily Volume:	.53M
Avg Daily Volume (30 D):	.63M
Avg Daily Volume (90 D):	.54M

Trade Size
Avg Trade Size (Sh.):	76
Avg Trade Size (Sh.) (30 D):	51
Avg Trade Size (Sh.) (90 D):	49

Institutional Trades
Total Institutional Trades:	3,518
Avg Institutional Trade:	$2.33M
Avg Institutional Trade (30 D):	$2.06M
Avg Institutional Trade (90 D):	$1.95M
Avg Institutional Trade Volume:	.09M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.8M
Avg Closing Trade (30 D):	$2.46M
Avg Closing Trade (90 D):	$2.21M
Avg Closing Volume:	117.82K

News

Apr 16, 2026 @ 6:37 PM CareDx Sharpens Focus On Core Testing Services Source: Vandana Singh

Feb 1, 2026 @ 8:16 AM CareDx's CEO Conducts Multiple Sale of Shares Towa... Source: Adé Hennis

May 22, 2025 @ 12:48 AM Johnson Fistel has Commenced an Investigation on B... Source: N/A

Sep 24, 2024 @ 6:42 PM ALERTA PARA LOS ACCIONISTAS: Morris Kandinov inves... Source: N/A

Sep 24, 2024 @ 10:00 AM SHAREHOLDER ALERT: Morris Kandinov Investigating C... Source: N/A

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-.16	$.05	$-.08
Diluted EPS	$-.16	$.05	$-.08
Revenue	$412.82M	$117.7M	$108.39M
Gross Profit
Net Income / Loss	$-8.19M	$2.81M	$-4.11M
Operating Income / Loss	$-16.21M	$1.2M	$-6.04M
Cost of Revenue
Net Cash Flow	$-10.82M	$12.48M	$-26.01M
PE Ratio